Quick Answer
ESCALON MEDICAL CORP reported Research And Development Expense of $753.1 thousand for the year ending 2025.
- ESCALON MEDICAL CORP showed an increase of +9.4% in Research And Development Expense from 2024 to 2025.
- This data is from ESCALON MEDICAL CORP's annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $396.2 thousand | Q4 2010: $406.4 thousand | Q1 2011: $395.7 thousand | Q3 2011: $219.6 thousand | Q4 2011: $210.5 thousand | Q1 2012: $300.4 thousand | Q3 2012: $264.2 thousand | Q4 2012: $266.2 thousand | Q1 2013: $272.9 thousand | Q3 2013: $323.2 thousand | Q4 2013: $377.0 thousand | Q1 2014: $315.9 thousand | Q3 2014: $324.3 thousand | Q4 2014: $383.7 thousand | Q1 2015: $289.8 thousand | Q3 2015: $359.8 thousand | Q4 2015: $382.8 thousand | Q1 2016: $370.2 thousand | Q3 2016: $310.4 thousand | Q4 2016: $286.1 thousand | Q1 2017: $279.9 thousand | Q3 2017: $193.1 thousand | Q4 2017: $107.5 thousand | Q1 2018: $92.6 thousand | Q3 2018: $96.4 thousand | Q4 2018: $226.3 thousand | Q1 2019: $218.0 thousand | Q3 2019: $245.6 thousand | Q4 2019: $261.8 thousand | Q1 2020: $301.0 thousand | Q3 2020: $209.3 thousand | Q4 2020: $244.5 thousand | Q1 2021: $215.7 thousand | Q3 2021: $291.2 thousand | Q4 2021: $260.4 thousand | Q1 2022: $229.3 thousand | Q3 2022: $264.2 thousand | Q4 2022: $191.3 thousand | Q1 2023: $185.8 thousand | Q3 2023: $211.7 thousand | Q4 2023: $147.7 thousand | Q1 2024: $155.8 thousand | Q3 2024: $140.9 thousand | Q4 2024: $155.9 thousand | Q1 2025: $164.8 thousand | Q3 2025: $216.1 thousand | Q4 2025: $131.2 thousand.
- Over the full 15 years of available data (2011 to 2025), ESCALON MEDICAL CORP's Research And Development Expense has declined by 53.0%.
- Historical annual values: Fiscal year 2025: $753.1 thousand | Fiscal year 2024: $688.2 thousand | Fiscal year 2023: $818.8 thousand | Fiscal year 2022: $991.0 thousand | Fiscal year 2021: $890.5 thousand | Fiscal year 2020: $1.12 million | Fiscal year 2019: $739.8 thousand | Fiscal year 2018: $500.3 thousand | Fiscal year 2017: $1.05 million | Fiscal year 2016: $1.45 million | Fiscal year 2015: $1.30 million | Fiscal year 2014: $1.31 million | Fiscal year 2013: $1.11 million | Fiscal year 2012: $1.00 million | Fiscal year 2011: $1.60 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: